logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

Cornerstone Research Group and MORSE Consulting form a Strategic Partnership

February 7, 2018
-
Market Access News, What's New
-
Posted by MORSE Team - 2 min read.

 

Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between our two organizations. This strategic partnership will simplify the logistical process for our clients utilizing our combined services when shepherding a product from reimbursement strategy, to CADTH submission and finally to pCPA negotiations. Together the collaboration between Cornerstone and MORSE offers clients a breadth of reimbursement consulting services that is unrivaled in the Canadian pharmaceutical market.

Over the past 13 years, Cornerstone has become a global leader in conducting health economics research, evidence synthesis, and value communication. Their skills have been honed in Canada – one of the world’s most restrictive reimbursement markets – and have been applied to a wide range of programs supporting pharmaceutical and medical device companies across the globe.

The MORSE Consulting team along with its strategic partners (IMPACT, DKDA, WestPAR) have rapidly developed a reputation for bringing together a unique blend of payer, commercial, and consulting expertise to tackle the most challenging problems facing pharmaceutical market access professionals.

“Cornerstone is well known for effectively addressing the most difficult issues related to health economics and Canadian reimbursement submissions. We are delighted to be able to collaborate with their team to expand the services that can now be offered to our clients,” said MORSE’s Managing Director Arvind Mani.

 

“We are pleased to be able to partner with MORSE, who are proven leaders in the area of pCPA and provincial negotiation,” added Cornerstone’s Partner Melissa Thompson.

Our organizations pride ourselves on our reputation for integrity, high-quality work, client relationships, and our ability to deliver value. Please feel free to contact Melissa Thompson (mthompson@cornerstone-research.com) or Arvind Mani (arvind@morseconsulting.ca) if you would like to learn more about how Cornerstone and MORSE can help you address your reimbursement needs.

 

Share
Tags
CADTH
CDR
Cornerstone
Cornerstone Research Group
DKDA
HTA
IMPACT
Medical Devices
MORSE Team
pCODR
pCPA
PE
Pharmacoeconomics
PLA
Reimbursement strategy
WestPAR
← PREVIOUS POST
pCPA Monthly Trends & Insights – January 2018
NEXT POST →
pCPA: 2017 Year in Review

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
Cornerstone Research Group and MORSE Consulting form a Strategic Partnership
Private
Public
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB

Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Public
Private
Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB